134 related articles for article (PubMed ID: 20050529)
1. Synthesis and pharmacological evaluation of new 1-[3-(4-phenylpiperazin-1-yl)-propyl]- and 1-[3-(4-phenylpiperidine)-propyl]- 3-aryl-3-alkyl-pyrrolidin-2-one derivatives with antiarrhythmic and antihypertensive activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Acta Pol Pharm; 2009; 66(6):649-62. PubMed ID: 20050529
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Nowaczyk A; Filipek B; Malawska B
Eur J Med Chem; 2009 Oct; 44(10):3994-4003. PubMed ID: 19447527
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxypropyl]-pyrrolidin-2-one derivatives with anti-arrhythmic, hypotensive, and alpha-adrenolytic activity.
Kulig K; Sapa J; Maciag D; Filipek B; Malawska B
Arch Pharm (Weinheim); 2007 Sep; 340(9):466-75. PubMed ID: 17806129
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological evaluation of pyrrolidin-2-one derivatives as antiarrhythmic, antihypertensive and alpha-adrenolytic agents.
Kulig K; Spieces C; Sapa J; Caspers C; Filipek B; Malawska B
Pharmacol Rep; 2010; 62(1):68-85. PubMed ID: 20360617
[TBL] [Abstract][Full Text] [Related]
5. Search for new antiarrhythmic and hypotensive compounds. Synthesis, antiarrhythmic, antihypertensive, and alpha-adrenoceptor blocking activity of novel 1-[(2-hydroxy-3-amino)]-propylpyrrolidin-2-one derivatives.
Filipek B; Sapa J; Malawska B; Kulig K; Antkiewicz-Michaluk L
Arch Pharm (Weinheim); 1997 Jul; 330(7):225-31. PubMed ID: 9311302
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and development of new 2-substituted 1-[3-(4-arylpiperazin-1-yl)propyl]-pyrrolidin-2-one derivatives with antiarrhythmic, hypotensive, and alpha-adrenolytic activity.
Malawska B; Kulig K; Gippert A; Filipek B; Sapa J; Maciag D
Farmaco; 2005 Oct; 60(10):793-803. PubMed ID: 16181628
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of some xanthone derivatives for anti-arrhythmic, hypotensive properties and their affinity for adrenergic receptors.
Marona H; Szkaradek N; Kubacka M; Bednarski M; Filipek B; Cegla M; Szneler E
Arch Pharm (Weinheim); 2008 Feb; 341(2):90-8. PubMed ID: 18240129
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, antiarrhythmic, and antihypertensive effects of novel 1-substituted pyrrolidin-2-one and pyrrolidine derivatives with adrenolytic activity.
Malawska B; Kulig K; Filipek B; Sapa J; Maciag D; Zygmunt M; Antkiewicz-Michaluk L
Eur J Med Chem; 2002 Mar; 37(3):183-95. PubMed ID: 11900863
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of in vivo activity of diphenylhydantoin basic derivatives.
Dylag T; Zygmunt M; Maciag D; Handzlik J; Bednarski M; Filipek B; Kieć-Kononowicz K
Eur J Med Chem; 2004 Dec; 39(12):1013-27. PubMed ID: 15571863
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic and α-Adrenoceptor Antagonistic Properties of Novel Arylpiperazine Derivatives of Pyrrolidin-2-one.
Zaręba P; Dudek M; Lustyk K; Siwek A; Starowicz G; Bednarski M; Nowiński L; Zygmunt M; Sapa J; Malawska B; Kulig K
Arch Pharm (Weinheim); 2015 Dec; 348(12):861-7. PubMed ID: 26523954
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic activity of novel S-enantiomers of pyrrolidin-2-one derivatives with adrenolytic properties.
Sapa J
Acta Pol Pharm; 2010; 67(5):537-42. PubMed ID: 20873423
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach.
Bhandari SV; Bothara KG; Patil AA; Chitre TS; Sarkate AP; Gore ST; Dangre SC; Khachane CV
Bioorg Med Chem; 2009 Jan; 17(1):390-400. PubMed ID: 19036593
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular activity of the chiral xanthone derivatives.
Szkaradek N; Rapacz A; Pytka K; Filipek B; Żelaszczyk D; Szafrański P; Słoczyńska K; Marona H
Bioorg Med Chem; 2015 Oct; 23(20):6714-24. PubMed ID: 26386822
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic and hypotensive activities of 1-[2-hydroxy-3-(4-phenyl-1-piperazinyl)propyl]-pyrrolidin-2-one (MG-1(R,S)) and its enantiomers.
Sapa J; Filipek B; Nowiński L
Pharmacol Rep; 2011; 63(2):455-63. PubMed ID: 21602601
[TBL] [Abstract][Full Text] [Related]
15. Preliminary evaluation of pharmacological properties of some xanthone derivatives.
Marona H; Szkaradek N; Rapacz A; Filipek B; Dybała M; Siwek A; Cegła M; Szneler E
Bioorg Med Chem; 2009 Feb; 17(3):1345-52. PubMed ID: 19131251
[TBL] [Abstract][Full Text] [Related]
16. Structure-cardiovascular activity relationships in a group of new 8-alkylamino-1,3-dimethyl-7-(2-hydroxy-3-aminopropyl)-3,7-dihydro-1H-purine-2,6-diones.
Chłoń-Rzepa G; Zmudzki P; Pawłowski M; Zygmunt M; Filipek B
Pharmacol Rep; 2011; 63(2):476-86. PubMed ID: 21602603
[TBL] [Abstract][Full Text] [Related]
17. The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α
Lustyk K; Sałaciak K; Siwek A; Sapa J; Zaręba P; Gałuszka A; Pytka K
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142287
[TBL] [Abstract][Full Text] [Related]
18. The structure-activity relationship of a new anti-arrhythmic agent 1-[2-acetoxy-3-(4-phenyl-1-piperazinyl)propyl]pyrrolidin-2-one.
Malawska B; Filipek B; Stadnicka K; Ciechanowicz-Rutkowska M
Arch Pharm (Weinheim); 1995 Jun; 328(6):541-6. PubMed ID: 7677570
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic and antihypertensive activity of some xanthone derivatives.
Marona H; Librowski T; Cegła M; Erdoğan C; Sahin NO
Acta Pol Pharm; 2008; 65(3):383-90. PubMed ID: 18646559
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis and biological activity of substituted benzyl/naphthylmethylisoquinolines and related quaternary ammonium derivatives].
Xu GY; Peng SX; Hua WY
Yao Xue Xue Bao; 1994; 29(2):95-106. PubMed ID: 8042518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
